12.18.12
Dr. Susan C. Stansfield has joined PharmaNet/i3, inVentiv Health’s clinical segment, as executive vice president of Clinical Operations for Phase II-IV Development in Europe, Middle East, and Africa (EMEA), Asia-Pacific, and Latin America.
Dr. Stansfield has successfully held senior leadership positions at other global clinical research organizations and has a proven record of significantly enhancing clinical operations.
“This appointment demonstrates PharmaNet/i3’s commitment to enhancing support for regional operations in parallel to our global cross-functional project management team,” said Dr. Robert M. Reekie, chief operating officer, Phase II-IV Development. “We believe Susan is a great addition to our talented global team that is focused on delivering the best possible service to our clients.”
Dr. Stansfield has successfully held senior leadership positions at other global clinical research organizations and has a proven record of significantly enhancing clinical operations.
“This appointment demonstrates PharmaNet/i3’s commitment to enhancing support for regional operations in parallel to our global cross-functional project management team,” said Dr. Robert M. Reekie, chief operating officer, Phase II-IV Development. “We believe Susan is a great addition to our talented global team that is focused on delivering the best possible service to our clients.”